27th September 2026, Sunday

TechPharus

Latest Posts

HealthTech News

  • Insomnia linked to higher risk of stroke
    on September 27, 2026 at 10:10 pm

    Insomnia is associated with a 26% higher risk of stroke and 28% higher odds of hospital admission, according to new research in Sleep Medicine Reviews. The researchers say the findings support recognizing insomnia as an important marker of brain, mental and general health.

  • Gut microbiome can reveal risk of type 2 diabetes
    on September 27, 2026 at 10:10 pm

    Changes in the composition of gut bacteria could provide an early warning of type 2 diabetes (T2D), according to new research being presented at the annual meeting of the European Association for the Study of Diabetes (EASD) in Milan, Italy, Sept. 28–Oct. 2.

  • Millions more people with overweight could benefit from GLP-1 drugs to protect heart health, study suggests
    on September 27, 2026 at 10:10 pm

    New research being presented at the annual meeting of the European Association for the Study of Diabetes (EASD) in Milan, Italy, Sept. 28–Oct. 2, makes a case for extending the indication for GLP-1 receptor agonists (GLP1-RAs) to millions more people to protect their heart health.

  • Sugar molecule in red meat linked to higher risk of developing type 2 diabetes
    on September 27, 2026 at 10:00 pm

    Preliminary results of an observational study presented at the annual meeting of the European Association for the Study of Diabetes (EASD) in Milan, Italy, Sept. 28–Oct. 2, show that high consumption of a sugar called dietary N-glycolylneuraminic acid (Neu5Gc), which is common in red meat, is associated with a 63% higher risk of developing type 2 diabetes (T2D). The association held after researchers accounted for other T2D risk factors, including physical activity, overall diet, smoking status and other health conditions.

  • Continuous glucose monitoring may lower mortality risk in diabetic patients on insulin
    on September 27, 2026 at 10:00 pm

    People with type 2 diabetes (T2D) who began using continuous glucose monitoring (CGM) while receiving basal insulin had a 44% lower risk of dying from any cause after one year than those who did not use CGM, according to an analysis of patient data being presented at the annual meeting of the European Association for the Study of Diabetes (EASD) in Milan, Italy, Sept. 28–Oct. 2. After two years, their risk was 35% lower.